Skip to content

ABFAB: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ABFAB

BE 0459.847.603
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€88,013
2024 · €101,101-€13,088
Equity
€2.4m
2024 · €2.4m+€88,013
Cash
€152,362
2024 · €103,000+€49,362
Balance sheet total
€2.5m
2024 · €2.4m+€88,188

Largest movements

2024 to 2025
Assets
  • Current investments +€99,256

    up €99,256 (+44.2%), from €224,528 to €323,784

  • Cash +€49,362

    up €49,362 (+47.9%), from €103,000 to €152,362

    mainly Net result for the year (+€88,013) and Depreciation (+€73,249)

  • Receivables within one year -€30,222

    down €30,222 (-35.3%), from €85,643 to €55,421

    of which Trade receivables: -€23,584

  • Tangible fixed assets -€28,213

    down €28,213 (-2.3%), from €1.2m to €1.2m

    of which Land and buildings: -€14,321

Equity and liabilities
  • Reserves +€88,013

    up €88,013 (+9.2%), from €961,380 to €1.0m

Income statement
  • Gross operating margin -€25,637

    down €25,637 (-11.2%), from €229,096 to €203,459

  • Taxes -€6,670

    down €6,670 (-13.8%), from €48,370 to €41,700

  • Financial income +€5,739

    up €5,739 (+245.4%), from €2,339 to €8,078

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €101,101
Gross operating margin -€25,637
Depreciation -€961
Other operating charges +€448
Financial income +€5,739
Financial charges +€653
Taxes +€6,670
Result 2025 €88,013

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€193,081
Investment -€143,719
Financing €0
Cash 2024 €103,000
Net result for the year +€88,013
Depreciation +€73,249
Stocks and contracts +€1,516
Receivables within one year +€30,222
Smaller working-capital items -€295
Trade debts -€572
Tax, wage and social debts -€1,309
Other debts +€2,258
Investment in fixed assets (net) -€44,463
Current investments -€99,256
Cash 2025 €152,362
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,369,394 €2,457,582 +€88,188 +3.7%
Fixed assets 21/28 €1,823,281 €1,794,494 -€28,786 -1.6%
Intangible fixed assets 21 €4,222 €3,649 -€573 -13.6%
Tangible fixed assets 22/27 €1,219,058 €1,190,845 -€28,213 -2.3%
Land and buildings 22 €1,176,819 €1,162,499 -€14,321 -1.2%
Plant, machinery and equipment 23 €35,177 €24,499 -€10,678 -30.4%
Furniture and vehicles 24 €7,062 €3,848 -€3,214 -45.5%
Financial fixed assets 28 €600,000 €600,000 = 0.0%
Current assets 29/58 €546,113 €663,087 +€116,974 +21.4%
Stocks and contracts in progress 3 €130,586 €129,070 -€1,516 -1.2%
Stocks 30/36 €130,586 €129,070 -€1,516 -1.2%
Amounts receivable within one year 40/41 €85,643 €55,421 -€30,222 -35.3%
Trade receivables 40 €64,792 €41,208 -€23,584 -36.4%
Other amounts receivable 41 €20,851 €14,213 -€6,638 -31.8%
Current investments 50/53 €224,528 €323,784 +€99,256 +44.2%
Cash at bank and in hand 54/58 €103,000 €152,362 +€49,362 +47.9%
Deferred charges and accrued income 490/1 €2,356 €2,450 +€94 +4.0%
Total equity and liabilities 10/49 €2,369,394 €2,457,582 +€88,188 +3.7%
Equity 10/15 €2,355,787 €2,443,800 +€88,013 +3.7%
Contributions 10/11 €1,394,407 €1,394,407 = 0.0%
Reserves 13 €961,380 €1,049,393 +€88,013 +9.2%
Distributable reserves 133 €961,380 €1,049,393 +€88,013 +9.2%
Amounts payable 17/49 €13,607 €13,782 +€175 +1.3%
Amounts payable within one year 42/48 €13,406 €13,782 +€376 +2.8%
Trade debts 44 €842 €270 -€572 -68.0%
Suppliers 440/4 €842 €270 -€572 -68.0%
Taxes, remuneration and social security 45 €10,110 €8,801 -€1,309 -12.9%
Taxes 450/3 €10,110 €8,801 -€1,309 -12.9%
Other amounts payable 47/48 €2,454 €4,711 +€2,258 +92.0%
Accrued charges and deferred income 492/3 €201 - -€201
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €72,289 €73,249 +€961 +1.3%
Other operating charges 640/8 €7,946 €7,498 -€448 -5.6%
Gross operating margin 9900 €229,096 €203,459 -€25,637 -11.2%
Operating profit (loss) 9901 €148,861 €122,711 -€26,150 -17.6%
Financial income 75/76B €2,339 €8,078 +€5,739 +245.4%
Recurring financial income 75 €2,339 €8,078 +€5,739 +245.4%
Financial charges 65/66B €1,729 €1,077 -€653 -37.7%
Recurring financial charges 65 €1,729 €1,077 -€653 -37.7%
Profit (loss) for the period before taxes 9903 €149,470 €129,713 -€19,758 -13.2%
Income taxes 67/77 €48,370 €41,700 -€6,670 -13.8%
Profit (loss) for the period 9904 €101,101 €88,013 -€13,088 -12.9%
Profit (loss) for the period to be appropriated 9905 €101,101 €88,013 -€13,088 -12.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.